Approaches for drug development in treatment of advanced melanoma
Pezzuto, J.M.; Shieh, H.L.; Shaughnessy, E.; Beattie, C.W.
Seminars in Oncology 15(6): 578-588
1988
ISSN/ISBN: 0093-7754 PMID: 3144740 Document Number: 316085
Document emailed within 1 workday
Related Documents
Anisimov, V.V.; Semiletova, Y.V.; Gafton, G.I.; Lemekhov, V.G.; Myasnyankin, M.Y.; Gafton, I.G. 2015: Comparative Evaluation of Surgical Approaches to Treatment of Patients with Skin Melanoma Voprosy Onkologii 61(3): 387-392Wallack, M.K. 1979: The treatment of advanced malignant melanoma with vaccina oncolysates La Nouvelle Presse Medicale 8(23): 1919-1921
Siegel, M.B.; Van Swearingen, A.E.D.; Anders, C.K. 2014: Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis Oncology 28(7): 579; 584-585
Carter, S.K. 1974: Anticancer drug development programs: a comparison of approaches in the United States, the Soviet Union, Japan, and Western Europe National Cancer Institute Monograph 40: 31-45
Volz, M.A.; Nelson, H.S. 1990: Drug allergy. Best diagnostic and treatment approaches Postgraduate Medicine 87(5): 137-42 149
Galstian, G.M.; Shutova, N.A.; Gorodetskiĭ, V.M. 2007: Antithrombin IIi in the treatment of sepsis-- new approaches to prescribing the old drug Anesteziologiia i Reanimatologiia 6: 66-71
Dorociak, R. 1981: Results of "5-drug" treatment of advanced breast cancer Polski Tygodnik Lekarski 36(38): 1467-1470
Pinedo, H.M. 2000: New development of treatment for locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 272-273
Herrera, G.A.; Peña, J.R.; Turbat-Herrera, E.A.; Kelly, D.R.; Shultz, J.J. 1994: The diagnosis of melanoma: current approaches addressing tumor differentiation Pathology Annual 29 Pt 1: 233-260
Le Doussal, V.; Brunet, M.; Guérin, P.; Hacene, K.; Lasry, S.; Marcotorchino, F.; Michaud, P.; Hebert, H.; Gest, J. 1981: Prognostic histopathological features of malignant melanoma. new statistical approaches La Nouvelle Presse Medicale 10(31): 2561-2563
Melita, P.; Barbuscia, M.; Calbo, L.; Belnome, N.A.; Palmeri, R.; Lazzara, S.; Lorenzini, C. 1989: Malignant melanoma of the skin: current diagnostic and therapeutic approaches Chirurgia Italiana 41(4-6): 167-179
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Kalaaji, A.N. 2007: Cytokine therapy in advanced melanoma Journal of Drugs in Dermatology: Jdd 6(4): 374-378
Jaques, D.P.; Coit, D.G.; Brennan, M.F. 1989: Major amputation for advanced malignant melanoma Surgery Gynecology and Obstetrics 169(1): 1-6
Nishimura, H.; Hamaguchi, K.; Miyahara, K.; Tazaki, T.; Tateno, N.; Yakushiji, M. 1990: The current therapeutic approaches to advanced ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 42(12): 1691-1696
Persons, D.L.; Arber, D.A.; Sosman, J.A.; Borelli, K.A.; Slovak, M.L. 2000: Amplification and overexpression of HER-2/neu are uncommon in advanced stage melanoma Anticancer Research 20(3b): 1965-1968
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Hochster, H.; Levin, M.; Speyer, J.; Dunleavy, S.; Harris, M.; Roses, D.; Golomb, F.; Muggia, F. 1985: Single-dose dacarbazine and dactinomycin in advanced malignant melanoma Cancer Treatment Reports 69(1): 39-42
Kroon, B.B.; Van Geel, A.N.; Benckhuijsen, C.; Wieberdink, J. 1987: Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs Anticancer Research 7(3 Part B): 441-442
Veliev, E.I. 2002: Modern approaches to treating locally-advanced and disseminated prostate cancer Terapevticheskii Arkhiv 74(10): 67-70